Blog

http://rpstransit.com/wp-content/plugins/LayerSlider/static/skins/     No not really!   A group of researchers have suggested lowering the p-value accepted for statistical significance from today’s most used 0.05 to 0.005.   While this may reduce some problems in clinical research it will give rise to some new.   And it is not at all where we should focus! (more…)

A real democratization of healthcare must include how to use research data by a supported understanding of findings from clinical trials. Democratization in healthcare is more than just a buzz word; it is important and is coming to live right now. Digital technology increases access to healthcare and at the same time support self-care. Patients…

Evaluating the results and their background in medical scientific papers and abstracts is complicated and time-consuming for healthcare providers, and more or less impossible without a medical education. Therefore press releases, personal pitches, headlines, and abstracts become a primary source for the news. However, is this trustworthy?   (more…)

At Zignifica we are proud that the Zignifica Team won the first place in the Galvanize / IBM Watson Cognitive Builder Hackathon in New York City May 12th to 14th 2017   The winning solution makes oncology patients aware about open/recruiting clinical trials using IBM Watson and location-based Foursquare services. Just another example of how HealthTech…

“It is scientifically proven” – “It is significant” – “The paper was in a high ranking Medical Journal” Arguments for trustworthiness and credibility of medical information are many, and often involves the words “scientific” or “significant” – best of all both. Unfortunately, does neither being “scientific” nor being “significant” equals being meaningful for patients and…

Zignifica Selected by IBM Watson and Galvanize for Cognitive Fair in NYC   At Zignifica we are happy and proud for being selected by IBM Watson and Galvanize to be part of the Cognitive Builder Fair in NYC May 12th-14th 2017. Zignifica will be presented both in an oral presentation and as an exhibitor and will be part…